What is the recommended regimen for initiating hypertension therapy with cilnidipine (CILACAR) and adding prazosin, including dosing, titration, monitoring, and contraindications?

Hypertension Treatment with Cilnidipine (CILACAR) and Prazosin

Initial Therapy with Cilnidipine

Start cilnidipine 10 mg once daily, either in the morning or at bedtime, as monotherapy for newly diagnosed hypertension or as add-on therapy to existing regimens. 1, 2

Dosing and Administration

• Initiate cilnidipine at 10 mg once daily, taken either in the morning or at bedtime—both timing options provide equivalent 24-hour blood pressure control without reflex tachycardia 3
• Titrate to 20 mg once daily after 2–4 weeks if blood pressure remains ≥140/90 mmHg 1, 4
• Bedtime dosing is particularly effective for controlling morning hypertension and reducing the morning blood pressure surge, which is associated with increased cardiovascular events 4, 5
• Cilnidipine reduces systolic blood pressure by approximately 17–20 mmHg and diastolic blood pressure by 10–12 mmHg when used as monotherapy 2, 4

Monitoring Parameters

• Measure blood pressure 2–4 weeks after initiation or dose adjustment 1
• Target blood pressure <130/80 mmHg for most patients, with a minimum acceptable goal of <140/90 mmHg 1
• Monitor heart rate—cilnidipine does not cause reflex tachycardia due to its N-type calcium channel blocking properties 3
• Achieve target blood pressure within 3 months of treatment initiation 1

Adding Prazosin to Cilnidipine

If blood pressure remains ≥140/90 mmHg on cilnidipine 20 mg daily, add a first-line agent (ACE inhibitor, ARB, or thiazide diuretic) before considering prazosin, which is reserved for resistant hypertension. 1

Stepwise Escalation Algorithm

Step 1: Optimize First-Line Dual Therapy

• For non-Black patients: Add an ACE inhibitor or ARB (e.g., lisinopril 10–40 mg daily or losartan 50–100 mg daily) to cilnidipine 1
• For Black patients: Add a thiazide or thiazide-like diuretic (chlorthalidone 12.5–25 mg daily preferred over hydrochlorothiazide 25 mg daily) to cilnidipine 1
• This combination targets complementary mechanisms: vasodilation through calcium channel blockade plus renin-angiotensin system inhibition or volume reduction 6

Step 2: Triple Therapy

• If blood pressure remains ≥140/90 mmHg after 2–4 weeks on dual therapy, add the third agent from the remaining class to create cilnidipine + ACE inhibitor/ARB + thiazide diuretic 1
• Check serum potassium and creatinine 2–4 weeks after adding a diuretic or ACE inhibitor/ARB 6

Step 3: Resistant Hypertension—Consider Prazosin

• Only after optimizing triple therapy (cilnidipine + ACE inhibitor/ARB + thiazide diuretic at maximum tolerated doses), consider adding a fourth agent 1
• Spironolactone 25–50 mg daily is the preferred fourth-line agent for resistant hypertension, providing additional reductions of 20–25/10–12 mmHg 6, 1
• Prazosin is an alternative fourth-line option when spironolactone is contraindicated (e.g., hyperkalemia, renal impairment) or not tolerated 6, 1

Prazosin Dosing and Titration

• Start prazosin 1 mg at bedtime to minimize first-dose syncope, which occurs in approximately 0.15% of patients 7
• Withhold diuretics for 1 day before initiating prazosin to reduce orthostatic hypotension risk 7
• Titrate gradually: increase to 1 mg twice daily after 3–7 days, then to 2 mg twice daily after another week if blood pressure remains elevated 7
• Maximum dose is typically 20 mg daily in divided doses (e.g., 10 mg twice daily), though most patients respond to 6–15 mg daily 7
• Take the first dose at bedtime and subsequent doses with food to minimize dizziness 7

Monitoring After Adding Prazosin

• Measure blood pressure in both sitting and standing positions to detect orthostatic hypotension, especially in elderly patients 6
• Monitor for fluid retention, which may develop on long-term prazosin therapy and necessitate diuretic dose adjustment 7
• Reassess blood pressure 2–4 weeks after each dose adjustment 1
• Check for ankle edema, which can occur with the cilnidipine-prazosin combination 6

Contraindications and Precautions

Cilnidipine Contraindications

• Severe hypotension (systolic BP <90 mmHg) 2
• Cardiogenic shock or acute myocardial infarction 2
• Severe aortic stenosis 2
• Pregnancy (use only if potential benefit justifies potential fetal risk) 2

Prazosin Contraindications

• Known hypersensitivity to quinazolines 7
• Use caution in patients with heart failure, as prazosin can cause fluid retention requiring diuretic addition 7
• Avoid in patients with severe coronary artery disease unless benefits outweigh risks 7

Special Populations

• Elderly patients: Start with lower doses of both agents and monitor closely for orthostatic hypotension 6, 7
• Renal impairment: Prazosin is particularly useful in patients with impaired renal function or on hemodialysis, as it does not require dose adjustment 7
• Diabetes mellitus: Both cilnidipine and prazosin are safe; prazosin does not disturb carbohydrate metabolism 7
• Hyperlipidemia: Prazosin may have favorable effects on lipid profiles 7

Critical Pitfalls to Avoid

• Do not use prazosin as a second-line agent—it is reserved for resistant hypertension after optimizing first-line triple therapy (ACE inhibitor/ARB + calcium channel blocker + thiazide diuretic) 1
• Do not start prazosin at doses >1 mg or without bedtime administration, as this increases first-dose syncope risk 7
• Do not combine an ACE inhibitor with an ARB (dual RAS blockade), as this increases hyperkalemia and acute kidney injury risk without added cardiovascular benefit 6
• Do not add a beta-blocker before optimizing diuretic therapy unless there are compelling indications (angina, post-MI, heart failure, atrial fibrillation) 6
• Do not delay treatment intensification when blood pressure remains ≥140/90 mmHg—reassess and adjust therapy every 2–4 weeks until target is achieved 1
• Do not assume treatment failure without first confirming medication adherence, excluding white-coat hypertension with home monitoring, and ruling out secondary causes 6, 1

Lifestyle Modifications (Adjunct to Pharmacotherapy)

• Sodium restriction to <2 g/day yields a 5–10 mmHg systolic reduction and enhances the efficacy of all antihypertensive classes 6
• Weight loss of approximately 10 kg reduces blood pressure by 6.0/4.6 mmHg in overweight patients 6
• DASH dietary pattern lowers blood pressure by approximately 11.4/5.5 mmHg 6
• Regular aerobic exercise (≥30 minutes most days) reduces blood pressure by approximately 4/3 mmHg 6
• Limit alcohol intake to ≤2 drinks/day for men and ≤1 drink/day for women 6